Work

Safety Analysis of Patients Who Received Ruxolitinib for the Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease in an Expanded Access Program

Year: 2020

Type: article

Source: Blood

DOI: 10.1182/blood-2020-140541

Authors: Parameswaran Hari, Haris Ali, Yi-Bin Chen, Salman Fazal, Tara K. Gregory, Sarah M. Anand, Ahmad Naim, Dilan Paranagama, Valkal Bhatt, Amy Blithe, John F. DiPersio

Institutions: Medical College of Wisconsin, City Of Hope National Medical Center, Massachusetts General Hospital, Allegheny Health Network, Colorado Blood Cancer Institute, University of Michigan, Incyte (United States), Washington University in St. Louis

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3095073084

FWCI:

Cites:

Cited by:

Related to: 10